Gapping up
In reaction to earnings/guidance:
- ATRO +7.5% (Q4 guidance), NFLX +6.4%, PPG +2.6%, RF +1.9%, HBAN +1.6%, SLB +1.5%, SIVB +1.2%
Other news:
- W +6.1% (update to cost efficiency plan - to reduce workforce by ~10%; expected to accelerate the timeline for adj EBITDA breakeven to earlier in 2023)
- CMPX +5.3% (announces Phase 2 data of CTX-009 to be presented)
- SGML +4.4% (files NI 43-101 Technical Report for production expansion supporting the previously announced 60% increase in mineral reserves and $ 15.3 billion NPV)
- GOOG +3.6% (decided to reduce its workforce by approximately 12000 roles)
- EXEL +3.3% (provides update on patent litigation with MSN Laboratories)
- EOSE +2.9% (investors pour $13.75 mln into convertible senior notes)
- MGNI +2.3% (reducing workforce by 6%)
- FTK +2.2% (appoints interim CEO and Chairman upon current CEO and Chairman's departure)
- ABCL +1.4% (announces that the U.S. Patent Trial and Appeal Board upholds microfluidic cell culture patent)
- COST +0.9% (reauthorizes repurchase program)
Analyst comments:
- PVH +1.3% (upgraded to Overweight from Equal Weight at Barclays)
- QSR +1.1% (upgraded to Outperform from Market Perform at BMO Capital Markets)
